Sign in

    David D. Guilmette

    Chief Executive Officer at Alight Inc
    Board
    Since August 20, 2024
    Age
    63 years
    Education
    Holds a B.A. in Political Science from the University of Chicago.
    Tenure
    Joined ALIT as a board member in 05-2024, was appointed Vice Chair in 07-2024, and became CEO on 08-20-2024.

    Also at Alight Inc

    APB
    Allison P. Bassiouni
    Chief Delivery Officer
    DD
    Deepika Duggirala
    Chief Technology Officer
    GAG
    Gregory A. George
    Chief Commercial Officer, North America

    About

    David D. Guilmette has built a distinguished career in the healthcare and benefits industry through senior leadership roles at major organizations, including serving as CEO of Global Health Solutions at Aon plc, President roles at Cigna Group, and Managing Director at Towers Perrin.

    Throughout his career, he has driven strategic transformation initiatives and performance enhancements, notably in his roles that involved innovation, commercial partnerships, and large-scale solution development. His leadership has been instrumental in executing significant operational shifts and promoting technology-rich services.

    At ALIT, his appointment as CEO on 08-20-2024, following his earlier involvement as a board member and Vice Chair, marks a transformative phase for the company. In addition to his executive responsibilities, he has engaged with non-profit initiatives and contributed to the broader industry through board positions with companies such as SwordHealth and entrepreneurial ventures like WorldClass Health.

    $ALIT Performance Under David D. Guilmette

    Past Roles

    OrganizationRoleDate RangeDetails
    Alight, Inc. (ALIT)Board MemberMay 2024 - August 2024 Served as a member of the Audit Committee prior to CEO appointment
    Aon plcStrategic Advisor to the CEO and PresidentFebruary 2023 - March 2024 Advised on innovation, large-scale solution development, commercial partnerships, and M&A strategy
    Aon plcCEO, Global Health SolutionsNovember 2019 - January 2023 Drove significant growth and profitability
    Cigna GroupPresident, Global Employer SegmentJuly 2012 - November 2019 Served on the Board of Managers of Cigna Ventures LLC and chaired the Innovation Advisory Board
    Cigna GroupPresident, National, Pharmacy & Product Division2010 - 2012 N/A
    Towers PerrinManaging Director, Global Health and Welfare BusinessFebruary 2005 - February 2010 N/A

    External Roles

    OrganizationRoleDate RangeDetails
    WorldClass HealthCo-founderSince March 2024 Active position
    SwordHealthBoard MemberSince August 2023 Active position

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Annual Base Salary$870,000 AnnualFixed base salary for 2024
    Time-Vested RSUs450,762 RSUs Vests in three equal installments on Oct 1, 2025, Oct 1, 2026, and Oct 1, 2027Vesting contingent on continued active service; grant effective date Oct 1, 2024

    Performance Compensation

    Data from  FY 2024

    Performance-Vested RSUs

    MetricMinimum (50%)Target (100%)Maximum (200%)
    Cumulative Revenue [USD, billions]$7.068 billion $7.225 billion $7.409 billion
    Cumulative Adjusted EBITDA [USD, billions]$1.803 billion $1.925 billion $2.028 billion

    Grant Details:

    • Grant Date: October 1, 2024
    • Target Number of RSUs: 450,762
    • Weights: 50% for Revenue Tranche and 50% for Adjusted EBITDA Tranche

    Evaluation Period & Vesting Schedule:

    • Measurement Period: January 1, 2024 to December 31, 2026
    • Certification Date: Within 60 days after the Measurement Period (by March 1, 2027)

    Additional Details:

    • Vesting is contingent upon achieving the specified performance thresholds in both metrics. The vesting percentage can range from 50% to 200% of the target RSUs based on performance.
    • Grant Date Fair Value and Grant Date Stock Price are not provided.